Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 8/20 | 0.75 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.75 |
| ▸ | P4HB | P07237 | 1/20 | 0.75 |
| ▸ | MAOB | P27338 | 10/20 | 0.72 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.67 |
| ▸ | MAOA | P21397 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL657470 | 1.00 | CYP1B1 (0.75) | CYP1B1CYP1A1P4HBMAOBCXCL12 | |
| SCHEMBL1225698 | 1.00 | CYP1B1 (0.75) | CYP1B1CYP1A1P4HBMAOBCXCL12 | |
| SCHEMBL1225700 | 1.00 | CYP1B1 (0.75) | CYP1B1CYP1A1P4HBMAOBCXCL12 | |
| Bromide SCHEMBL11819636 | 0.98 | CYP1B1 (0.73) | CYP1B1CYP1A1P4HBMAOBCXCL12 | |
| Bromide SCHEMBL11817481 | 0.98 | CYP1B1 (0.73) | CYP1B1CYP1A1P4HBMAOBCXCL12 | |
| Hydrochloric Acid SCHEMBL11814001 | 0.98 | CYP1B1 (0.73) | CYP1B1CYP1A1P4HBMAOBCXCL12 | |
| Hydrochloric Acid SCHEMBL11814006 | 0.98 | CYP1B1 (0.73) | CYP1B1CYP1A1P4HBMAOBCXCL12 | |
| Bromide SCHEMBL11819641 | 0.98 | CYP1B1 (0.73) | CYP1B1CYP1A1P4HBMAOBCXCL12 | |
| Bromide SCHEMBL11817475 | 0.98 | CYP1B1 (0.73) | CYP1B1CYP1A1P4HBMAOBCXCL12 | |
| SCHEMBL11816722 | 0.92 | CYP1A1 (0.87) | CYP1B1CYP1A1P4HBMAOBCXCL12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2349999-B1 | ALLOSTERIC PROTEIN KINASE MODULATORS | UNIV SAARLAND (DE) | 2016-01-27 | — | — | EP | disclosed |
| US-8912186-B2 | Allosteric protein kinase modulators | UNIVERSITAET DES SAARLANDES (DE) | 2014-12-16 | — | — | US | disclosed |
| US-20120046307-A1 | ALLOSTERIC PROTEIN KINASE MODULATORS | UNIVERSITAET DES SAARLANDES (DE) | 2012-02-23 | — | — | US | disclosed |
| EP-2349999-A1 | ALLOSTERIC PROTEIN KINASE MODULATORS | Universität des Saarlandes (DE) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010043711-A1 | ALLOSTERIC PROTEIN KINASE MODULATORS | UNIVERSITAET DES SAARLANDES (DE) | 2010-04-22 | — | — | WO | disclosed |
| US-3931152-A | ANTITUBERCULAR | AMERICAN CYANAMID COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046307-A1 | ALLOSTERIC PROTEIN KINASE MODULATORS | AURKC, AURKA, AURKB | CYP1B1 4714/4885CYP1A1 4763/4885P4HB 4502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.